Biogen (BIIB) Sales of Property, Plant and Equipment (2021 - 2024)

Biogen (BIIB) Sales of Property, Plant and Equipment (2021 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	36.40 Mn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	-
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	29.00 Mn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	-
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	-
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	-
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	-
10	Biogen	28.75 Bn	24.47 Bn	1.82 Bn	-

Download Data